BridgeBio Pharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $5,882 | $2,732 | $2,168 | $211,120 |
Gross Profit | 5,882 | 2,134 | 1,570 | 209,226 |
EBITDA | -226,027 | -139,655 | -51,033 | -11,093 |
EBIT | -141,193 | -52,607 | -12,689 | |
Net Income | -265,050 | -162,040 | -73,456 | -35,216 |
Net Change In Cash | 5,882 | 2,732 | 2,168 | 211,120 |
Free Cash Flow | -182,298 | 72,256 | -221,029 | |
Cash | 681,101 | 266,324 | 407,958 | 475,353 |
Basic Shares | 189,437 | 188,510 | 187,586 | 178,705 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $221,902 | $9,303 | $77,648 | $69,716 |
Gross Profit | 218,024 | 6,857 | 74,214 | 66,602 |
EBITDA | -592,973 | -565,468 | -397,443 | -533,833 |
EBIT | -571,962 | -404,214 | -539,676 | |
Net Income | -535,762 | -643,202 | -493,964 | -639,297 |
Net Change In Cash | 221,902 | 9,303 | 77,648 | 69,716 |
Cost of Revenue | 20,519 | 37,686 | ||
Free Cash Flow | -521,659 | -529,026 | -425,815 | -546,180 |
Cash | 681,101 | 375,935 | 376,689 | 393,772 |
Basic Shares | 186,075 | 162,791 | 147,473 | 144,356 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.37 |
2024-09-30 | -$0.85 |
2024-06-30 | -$0.39 |
2024-03-31 | -$0.20 |
